Suppr超能文献

澳大利亚出院后持续使用阿片类药物:系统评价。

Persistent opioid use after hospital discharge in Australia: a systematic review.

机构信息

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia; and Caboolture Hospital Pharmacy Department, Metro North Health, Queensland Health, Caboolture, Qld, Australia.

Clinical Pharmacology Department, Royal Brisbane and Women's Hospital, Queensland Health, Herston, Qld, Australia.

出版信息

Aust Health Rev. 2022 Jun;46(3):367-380. doi: 10.1071/AH21353.

Abstract

Objective This systematic review identified studies that provided an estimate of persistent opioid use following patient discharge from hospital settings in Australia. Methods A literature search was performed on 5 December 2020, with no date restrictions to identify studies that reported a rate of persistent opioid use following patient discharge from Australian Hospitals. The search strategy combined all terms relating to the themes 'hospital patients', 'prescribing', 'opioids' and 'Australia'. Studies that dealt solely with cancer, palliative care or addiction medicine were excluded. The databases searched in this review were Embase, PubMed, Scopus, CINAHL, and International Pharmaceutical Abstracts. Studies were assessed for bias using the Newcastle-Ottawa Scale and considered against international literature. Results In total, 13 publications are included for final analysis in this review. Of these, 11 articles relate to post-surgical opioid use. With one exception, studies were of a 'good' quality. Methods of data collection in included studies were a mixture of those conducting follow up of patients directly over time and those utilising dispensing databases. Persistent opioid use among surgical patients generally ranged from 3.9 to 10.5% at between 2 and 4 months after discharge. Conclusions How rates of persistent opioid use following hospital encounters in Australia are established, and how long after discharge rates are reported, is heterogeneous. Literature primarily relates to post-surgical patients, with very few studies investigating other settings such as encounters with the emergency department.

摘要

目的

本系统评价旨在确定澳大利亚医院出院患者持续使用阿片类药物的研究。

方法

2020 年 12 月 5 日进行文献检索,不设日期限制,以确定报告澳大利亚医院出院患者持续使用阿片类药物的发生率的研究。检索策略将与“医院患者”、“处方”、“阿片类药物”和“澳大利亚”相关的所有术语结合起来。本研究排除了仅涉及癌症、姑息治疗或药物成瘾的研究。本综述中检索的数据库包括 Embase、PubMed、Scopus、CINAHL 和国际药学文摘。使用纽卡斯尔-渥太华量表评估研究偏倚,并与国际文献进行比较。

结果

共有 13 篇出版物最终纳入本综述进行分析。其中,11 篇文章与术后阿片类药物使用有关。除了一篇文章,其他研究的质量都很好。纳入研究中数据收集的方法既有对患者进行直接随时间随访的方法,也有利用配药数据库的方法。术后患者的持续阿片类药物使用一般在出院后 2 至 4 个月时为 3.9%至 10.5%。

结论

澳大利亚医院就诊后持续使用阿片类药物的发生率以及报告出院后多久的发生率存在差异。文献主要涉及术后患者,很少有研究调查其他情况,如与急诊部门的接触。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验